Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03972683Phase 1Withdrawn
Phase 1, open-label, single-arm trial, sponsored by Colorado State University. Primary endpoint: Functional sympatholysis. Planned start Apr 2019; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03972683.